T1	Participants 80 106	stage I endometrial cancer
T2	Participants 190 261	stage I endometrial cancer with the traditional transabdominal approach
T3	Participants 292 344	61 patients with clinical stage I endometrial cancer
T4	Participants 438 458	Twenty-nine patients
